Acadian Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

Acadian Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-44,288	Closed	-$143K	–	2028
2026 Q1	$143K	Hold	44,288	–	–	﹤0.01%	1669
2025 Q4	$176K	Hold	44,288	–	–	﹤0.01%	1547
2025 Q3	$138K	Hold	44,288	–	–	﹤0.01%	1454
2025 Q2	$148K	Sell	44,288 -4,849	-10%	-$23K	﹤0.01%	1353
2025 Q1	$207K	Sell	49,137 -139,027	-74%	-$576K	﹤0.01%	1254
2024 Q4	$444K	Hold	188,164	–	–	﹤0.01%	1100
2024 Q3	$239K	Hold	188,164	–	–	﹤0.01%	1300
2024 Q2	$286K	Hold	188,164	–	–	﹤0.01%	1349
2024 Q1	$315K	Hold	188,164	–	–	﹤0.01%	1102
2023 Q4	$326K	Hold	188,164	–	–	﹤0.01%	1124
2023 Q3	$354K	Hold	188,164	–	–	﹤0.01%	1087
2023 Q2	$275K	Hold	188,164	–	–	﹤0.01%	1201
2023 Q1	$366K	Hold	188,164	–	–	﹤0.01%	1127
2022 Q4	$422K	Hold	188,164	–	–	﹤0.01%	1083
2022 Q3	$451K	Hold	188,164	–	–	﹤0.01%	1017
2022 Q2	$390K	Sell	188,164 -79	-0%	-$183	﹤0.01%	1043
2022 Q1	$529K	Buy	188,243 +40,949	+28%	+$136K	﹤0.01%	978
2021 Q4	$683K	Sell	147,294 -14,923	-9%	-$50.9K	﹤0.01%	924
2021 Q3	$429K	Sell	162,217 -6,189	-4%	-$18.4K	﹤0.01%	1091
2021 Q2	$480K	Sell	168,406 -6,609	-4%	-$19.4K	﹤0.01%	1170
2021 Q1	$529K	Buy	175,015 +69,997	+67%	+$228K	﹤0.01%	1175
2020 Q4	$310K	Hold	105,018	–	–	﹤0.01%	1394
2020 Q3	$339K	Buy	105,018 +2,400	+2%	+$7.89K	﹤0.01%	1262
2020 Q2	$344K	Buy	102,618 +9,975	+11%	+$36.3K	﹤0.01%	1321
2020 Q1	$335K	Sell	92,643 -5,549	-6%	-$24.8K	﹤0.01%	1063
2019 Q4	$506K	Sell	98,192 -3,088	-3%	-$16.3K	﹤0.01%	1067
2019 Q3	$601K	Sell	101,280 -3,218	-3%	-$17.9K	﹤0.01%	1034
2019 Q2	$665K	Buy	104,498 +6,765	+7%	+$41K	﹤0.01%	922
2019 Q1	$566K	Hold	97,733	–	–	﹤0.01%	1071
2018 Q4	$588K	Hold	97,733	–	–	﹤0.01%	862
2018 Q3	$559K	Sell	97,733 -10,753	-10%	-$63.3K	﹤0.01%	858
2018 Q2	$664K	Buy	108,486 +1,164	+1%	+$7.28K	﹤0.01%	823
2018 Q1	$718K	Sell	107,322 -19,475	-15%	-$134K	﹤0.01%	783
2017 Q4	$933K	Sell	126,797 -1,630	-1%	-$12K	﹤0.01%	701
2017 Q3	$907K	Sell	128,427 -1,646	-1%	-$11.4K	﹤0.01%	698
2017 Q2	$911K	Sell	130,073 -357	-0.3%	-$2.35K	﹤0.01%	722
2017 Q1	$905K	Buy	130,430 +4,257	+3%	+$25.8K	﹤0.01%	779
2016 Q4	$692K	Sell	126,173 -7,304	-5%	-$38.1K	﹤0.01%	789
2016 Q3	$667K	Sell	133,477 -2,724	-2%	-$12.8K	﹤0.01%	758
2016 Q2	$613K	Buy	136,201 +117	+0.1%	+$536	﹤0.01%	724
2016 Q1	$611K	Sell	136,084 -32,434	-19%	-$155K	﹤0.01%	714
2015 Q4	$889K	Sell	168,518 -5,966	-3%	-$34K	﹤0.01%	708
2015 Q3	$1.01M	Buy	174,484 +129	+0.1%	+$804	0.01%	675
2015 Q2	$1.25M	Buy	174,355 +91,900	+111%	+$639K	0.01%	645
2015 Q1	$548K	Buy	82,455 +55,196	+202%	+$345K	﹤0.01%	751
2014 Q4	$162K	Hold	27,259	–	–	﹤0.01%	921
2014 Q3	$135K	Sell	27,259 -3,991	-13%	-$19.3K	﹤0.01%	805
2014 Q2	$141K	Sell	31,250 -1,763	-5%	-$7.87K	﹤0.01%	831
2014 Q1	$149K	Sell	33,013 -6,048	-15%	-$28.8K	﹤0.01%	811
2013 Q4	$200K	Hold	39,061	–	–	﹤0.01%	808
2013 Q3	$177K	Buy	+39,061	New	+$194K	﹤0.01%	759

Other funds holding CPIX

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Bailard Foster City, California $4.91B AUM 31.75% 1-Year Est. Return

Acadian Asset Management's CPIX Position: Q2 2026 in Review

Acadian Asset Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2026, closing a stake of 44,288 shares — an estimated $143K sold.

Acadian Asset Management first reported a position in CPIX in Q3 2013 and held it in 51 quarters. The position peaked at $1.25M in Q2 2015. 20 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.

Acadian Asset Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Acadian Asset Management sold 44,288 Cumberland Pharmaceuticals shares in Q2 2026, an estimated $143K.
Acadian Asset Management first reported a position in Cumberland Pharmaceuticals in Q3 2013 and held it in 51 quarters.
Acadian Asset Management's Cumberland Pharmaceuticals position peaked at $1.25M in Q2 2015.
20 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.